Get all your news in one place.
100's of premium titles.
One app.
Start reading
Euronews
Euronews
Marta Iraola Iribarren

First Bundibugyo Ebola vaccine to start human trials in the UK

The University of Oxford’s Vaccine Group has launched the world’s first human clinical trial of a vaccine against Bundibugyo Ebolavirus amid the ongoing outbreak in the Democratic Republic of the Congo and Uganda.

The Phase I clinical trial will take place in Oxford and will assess the safety and immune response of the vaccine in 50 healthy adults aged between 18 and 55.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.